Anti-CD22 (RFB4)-mcc-DM1 ADC (CAT#: ADC-028LCT)

• Antibody Overview
• Murine Anti-Human CD22 Antibody (RFB4)

• Clone
• RFB4

• Linker
• mcc (Maleimidomethyl cyclohexane-1-carboxylate)

• Linker Class/Description
• Noncleavable linker is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.

• Drug
• DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

• Drug Class/Description
• Maytansinoids are a group of cytotoxins structurally similar to rifamycin, geldanamycin, and ansatrienin. The eponymous natural cytotoxic agent maytansine is a 19-member lactam (ansa
  macrolide) structure originally isolated from the Ethiopian shrub Maytenus ovatus. Maytansinoids can bind to tubulin at or near the vinblastine-binding site, which interfere the formation of microtubules and depolymerize already formed microtubules, inducing mitotic arrest in the intoxicated cells

• Introduction
• CD22, or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases.
  CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling. It is also involved in the B cell trafficking to Peyer's patches in mice.

• Alternative Names
• CD22; CD22 molecule; SIGLEC2; SIGLEC-2; B-cell receptor CD22; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; B-lymphocyte cell adhesion molecule; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2;

• Gene ID
• 933

• UniProt ID
• P20273

• AGTO-G077E
• Anti-CD22 immunotoxin RFB4 (IgG)-PE

• AGTO-L048E
• anti-CD22 immunotoxin RFB4 (scFv)-PE

• AGTO-G077D
• Anti-CD22 immunotoxin RFB4 (IgG)-DT

• AGTO-G077G
• Anti-CD22 immunotoxin RFB4 (IgG)-Gel

• AGTO-L048D
• anti-CD22 immunotoxin RFB4 (scFv)-DT

• AGTO-G077R
• Anti-CD22 immunotoxin RFB4 (IgG)-RTA

• AGTO-G077S
• Anti-CD22 immunotoxin RFB4 (IgG)-Sap

• AGTO-L048G
• anti-CD22 immunotoxin RFB4 (scFv)-Gel

• AGTO-L048R
• anti-CD22 immunotoxin RFB4 (scFv)-RTA

• AGTO-L048S
• anti-CD22 immunotoxin RFB4 (scFv)-Sap

• ADC-224CL
• Anti-CD22 (clone RFB4)-SMCC-DM1 ADC

• ADC-225CL
• Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAF ADC

• ADC-226CL
• Anti-CD22 (clone RFB4)-MC-MMAF ADC

• ADC-227CL
• Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAE ADC

• TAB-1728CL
• Anti-Human CD22 Recombinant Antibody (RFB4)

Select a product category from the dropdown menu below to view related products.